Study Results & Research Projects

Pathology Tables for Peer Review

The National Toxicology Program

Print this page Easy Link

http://ntp.niehs.nih.gov/go/27933

NTP Experiment-Test: 98004-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: SUBCHRON 90-DAY                                 HEXACHLOROBENZENE                                     Date: 10/23/02
Route: GAVAGE                                                                                                     Time: 10:18:30

                                                          Final#1/Rats




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  118-74-1

       Lock Date:  01/17/02

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 98004-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                 HEXACHLOROBENZENE                                     Date: 10/23/02    
Route: GAVAGE                                                                                                     Time: 10:18:30    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                0 MG/KG      0.03         0.1          0.3          1.0          3.0             
                                                                MG/KG        MG/KG        MG/KG        MG/KG        MG/KG           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          10           10           10           10           10           10           
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                              1                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                10            9           10           10           10           10           
                                                                                                                                    
  Animals Examined Microscopically                    10           10           10           10           10           10           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Liver                                              (10)         (10)         (10)         (10)         (10)         (10)         
      Clear Cell Focus                                              1 (10%)      1 (10%)                                1 (10%)     
      Hematopoietic Cell Proliferation                                                        1 (10%)                   1 (10%)     
      Hepatodiaphragmatic Nodule                       1 (10%)                                1 (10%)                   1 (10%)     
      Infiltration Cellular, Mixed Cell                8 (80%)      6 (60%)      5 (50%)      9 (90%)      6 (60%)      9 (90%)     
   Oral Mucosa                                        (3)                                                                           
      Gingival, Inflammation                           3 (100%)                                                                     
   Pancreas                                           (10)         (1)                                                              
      Acinus, Atrophy                                  1 (10%)                                                                      
   Tongue                                             (10)         (1)                                                              
      Vein, Dysplasia                                  1 (10%)                                                                      
   Tooth                                              (10)         (10)         (10)         (10)         (10)         (10)         
      Incisor, Degeneration                                                                                5 (50%)     10 (100%)    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Thyroid Gland                                      (10)         (10)         (10)         (10)         (10)         (9)          
      Ultimobranchial Cyst                             1 (10%)      3 (30%)      3 (30%)      2 (20%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 98004-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                 HEXACHLOROBENZENE                                     Date: 10/23/02    
Route: GAVAGE                                                                                                     Time: 10:18:30    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                0 MG/KG      0.03         0.1          0.3          1.0          3.0             
                                                                MG/KG        MG/KG        MG/KG        MG/KG        MG/KG           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ovary                                              (10)         (1)                                                              
      Corpus Luteum, Cyst                              2 (20%)                                                                      
   Uterus                                             (10)         (1)                                                              
      Endometrium, Hyperplasia, Cystic                 1 (10%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Spleen                                             (10)         (10)         (10)         (10)         (10)         (10)         
      Hematopoietic Cell Proliferation                 3 (30%)      4 (40%)      4 (40%)      3 (30%)      4 (40%)      6 (60%)     
      Pigmentation, Hemosiderin                       10 (100%)     8 (80%)     10 (100%)    10 (100%)    10 (100%)    10 (100%)    
   Thymus                                             (10)         (10)         (10)         (10)         (10)         (10)         
      Atrophy                                                       1 (10%)                                                         
      Cyst                                             1 (10%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (10)         (10)         (10)         (10)         (10)         (10)         
      Hyperplasia                                      2 (20%)      2 (20%)      1 (10%)                   2 (20%)      2 (20%)     
   Skin                                               (10)         (10)         (9)          (10)         (10)         (9)          
      Hair Follicle, Inflammation, Chronic Active,                                                                                  
         Focal                                                                                                          1 (11%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (10)         (10)         (10)         (10)         (10)         (10)         
      Inflammation, Chronic                            3 (30%)      1 (10%)      1 (10%)      2 (20%)      7 (70%)      8 (80%)     
      Alveolar Epithelium, Hyperplasia                                                                     2 (20%)                  
      Alveolus, Inflammation, Suppurative                                                                               1 (10%)     
      Bronchiole, Hyperplasia                                                                              2 (20%)                  
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 98004-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                 HEXACHLOROBENZENE                                     Date: 10/23/02    
Route: GAVAGE                                                                                                     Time: 10:18:30    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                0 MG/KG      0.03         0.1          0.3          1.0          3.0             
                                                                MG/KG        MG/KG        MG/KG        MG/KG        MG/KG           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Perivascular, Infiltration Cellular,                                                                                          
        Polymorphonuclear                              1 (10%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (10)         (1)                                                              
      Nephropathy                                      7 (70%)      1 (100%)                                                        
      Cortex, Mineralization                                        1 (100%)                                                        
      Papilla, Mineralization                          4 (40%)      1 (100%)                                                        
      Renal Tubule, Accumulation, Hyaline Droplet      1 (10%)                                                                      
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 98004-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                 HEXACHLOROBENZENE                                     Date: 10/23/02    
Route: GAVAGE                                                                                                     Time: 10:18:30    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                10.0         25.0                                                                
                                                   MG/KG        MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          10           10                                                               
  Early Deaths                                                                                                                      
  Survivors                                                                                                                         
    Terminal Sacrifice                                10           10                                                               
                                                                                                                                    
  Animals Examined Microscopically                    10           10                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Liver                                              (10)         (10)                                                             
      Hematopoietic Cell Proliferation                 1 (10%)                                                                      
      Infiltration Cellular, Mixed Cell               10 (100%)    10 (100%)                                                        
      Vacuolization Cytoplasmic, Focal                              2 (20%)                                                         
      Hepatocyte, Hypertrophy                          9 (90%)     10 (100%)                                                        
   Tooth                                              (10)         (10)                                                             
      Incisor, Degeneration                           10 (100%)    10 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Thyroid Gland                                      (10)         (10)                                                             
      Ultimobranchial Cyst                             2 (20%)      3 (30%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ovary                                                           (10)                                                             
      Corpus Luteum, Cyst                                           1 (10%)                                                         
   Uterus                                                          (10)                                                             
      Endometrium, Hyperplasia, Cystic                              2 (20%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 98004-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                 HEXACHLOROBENZENE                                     Date: 10/23/02    
Route: GAVAGE                                                                                                     Time: 10:18:30    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                10.0         25.0                                                                
                                                   MG/KG        MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Spleen                                             (10)         (10)                                                             
      Hematopoietic Cell Proliferation                 5 (50%)      6 (60%)                                                         
      Hyperplasia, Lymphoid                            6 (60%)      8 (80%)                                                         
      Pigmentation, Hemosiderin                        8 (80%)      9 (90%)                                                         
   Thymus                                             (10)         (10)                                                             
      Atrophy                                                       3 (30%)                                                         
      Cyst                                                          1 (10%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (10)         (10)                                                             
      Hyperplasia                                      3 (30%)     10 (100%)                                                        
   Skin                                               (10)         (10)                                                             
      Inflammation, Suppurative                                     9 (90%)                                                         
      Ulcer                                                         7 (70%)                                                         
      Dermis, Infiltration Cellular, Mononuclear                                                                                    
        Cell                                           1 (10%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (10)         (10)                                                             
      Inflammation, Chronic                           10 (100%)    10 (100%)                                                        
      Bronchiole, Hyperplasia                          2 (20%)                                                                      
      Interstitium, Fibrosis, Focal                                 1 (10%)                                                         
   Trachea                                            (1)                                                                           
      Degeneration                                     1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 98004-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                 HEXACHLOROBENZENE                                     Date: 10/23/02    
Route: GAVAGE                                                                                                     Time: 10:18:30    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                10.0         25.0                                                                
                                                   MG/KG        MG/KG                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                                          (10)                                                             
      Nephropathy                                                   9 (90%)                                                         
      Papilla, Mineralization                                       4 (40%)                                                         
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------